Manulife (Manufacturers Life Insurance)’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Sell |
19,887
-2,524
| -11% | -$17.4K | ﹤0.01% | 2694 |
|
|
2025
Q1 | $64.5K | Sell |
22,411
-1,059
| -5% | -$3.05K | ﹤0.01% | 2794 |
|
|
2024
Q4 | $110K | Sell |
23,470
-304
| -1% | -$1.43K | ﹤0.01% | 2798 |
|
|
2024
Q3 | $84.9K | Sell |
23,774
-706
| -3% | -$2.52K | ﹤0.01% | 2902 |
|
|
2024
Q2 | $152K | Buy |
+24,480
| New | +$152K | ﹤0.01% | 2705 |
|
|
2023
Q2 | – | Sell |
-17,020
| Closed | -$48.5K | – | 3002 |
|
|
2023
Q1 | $48.5K | Hold |
17,020
| – | – | ﹤0.01% | 2863 |
|
|
2022
Q4 | $124K | Buy |
17,020
+2,009
| +13% | +$14.6K | ﹤0.01% | 2742 |
|
|
2022
Q3 | $121K | Buy |
15,011
+41
| +0.3% | +$332 | ﹤0.01% | 2755 |
|
|
2022
Q2 | $73.4K | Buy |
14,970
+3,398
| +29% | +$16.7K | ﹤0.01% | 2975 |
|
|
2022
Q1 | $274K | Sell |
11,572
-2,769
| -19% | -$65.5K | ﹤0.01% | 2569 |
|
|
2021
Q4 | $254 | Buy |
14,341
+334
| +2% | +$6 | ﹤0.01% | 2737 |
|
|
2021
Q3 | $395K | Buy |
+14,007
| New | +$395K | ﹤0.01% | 2459 |
|
|
2021
Q2 | – | Sell |
-11,460
| Closed | -$135K | – | 3239 |
|
|
2021
Q1 | $135K | Buy |
+11,460
| New | +$135K | ﹤0.01% | 3006 |
|